Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - zoledronic acid monohydrate, quantity: 4.3 mg (equivalent: zoledronic acid, qty 4 mg) - injection, concentrated - excipient ingredients: water for injections; mannitol; sodium citrate dihydrate - ? prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in patients with advanced malignancies involving bone.,? treatment of tumour-induced hypercalcaemia

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - zoledronic acid monohydrate 5.33mg equivalent to zolendronic acid (anhydrous) 5mg - solution for infusion - 5 mg/100ml - active: zoledronic acid monohydrate 5.33mg equivalent to zolendronic acid (anhydrous) 5mg excipient: mannitol sodium citrate water for injection - · treatment of osteoporosis in postmenopausal women to reduce the incidence of hip, vertebral and non-vertebral fractures and to increase bone mineral density. · prevention of postmenopausal osteoporosis.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo pharma b.v. - zoledronic acid monohydrate 42,64 µg/ml - eq. zoledronic acid 0,04 mg/ml - solution for infusion - 4 mg/100 ml - zoledronic acid monohydrate 42.64 µg/ml - zoledronic acid

Canada - English - Health Canada

taro pharmaceuticals inc - zoledronic acid (zoledronic acid monohydrate) - solution - 4mg - zoledronic acid (zoledronic acid monohydrate) 4mg - bone resorption inhibitors

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - zoledronic acid monohydrate, quantity: 4.264 mg (equivalent: zoledronic acid, qty 4 mg) - injection, concentrated - excipient ingredients: sodium citrate dihydrate; mannitol; water for injections - zoledronic acid accord is indicated:,for the prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in patients with advanced malignancies involving bone.,for treatment of tumour-induced hypercalcaemia.,as an adjunct to adjuvant treatment for women with early breast cancer who are in established menopause.

Canada - English - Health Canada

sandoz canada incorporated - zoledronic acid (zoledronic acid monohydrate) - solution - 4mg - zoledronic acid (zoledronic acid monohydrate) 4mg - bone resorption inhibitors

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk - zoledronic acid monohydrate - solution for infusion - 40microgram/1ml

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - solution for infusion - zoledronic acid 5/100 mg/ml - drugs for treatment of bone diseases

Ireland - English - HPRA (Health Products Regulatory Authority)

cipla (eu) limited - zoledronic acid monohydrate - solution for infusion - 5mg/100 millilitre - biphosphonates

Kenya - English - Pharmacy and Poisons Board

zolendronic acid - solution for infusion - 4mg/5ml - zoledronic acid calcium and colecalciferol